May 9, 2024 04:01PM
Mar 25, 2024 04:01PM
Nov 28, 2023 08:00AM
Nov 28, 2023 08:00AM
Feb 21, 2023 08:30AM
Feb 21, 2023 08:30AM
Feb 21, 2023 08:30AM eFFECTOR Therapeutics Announces Positive Top-Line Results from Phase 1b Clinical Trial of Zotatifin for the Treatment of COVID
Jan 5, 2023 04:01PM
Jan 5, 2023 04:01PM
Jan 5, 2023 04:01PM
Apr 4, 2022 08:32AM
Apr 4, 2022 08:30AM
Apr 4, 2022 08:30AM
Jan 24, 2022 04:02PM eFFECTOR Therapeutics (EFTR) Issues Pipeline and Business Updates
Jan 24, 2022 04:00PM
Jan 24, 2022 04:00PM
Nov 8, 2021 07:00AM
Nov 8, 2021 07:00AM
Oct 7, 2021 04:37PM
Oct 7, 2021 04:30PM
Oct 7, 2021 04:30PM Baylor College of Medicine Presents eFFECTOR Therapeutics-Backed Preclinical Data Supporting Development of Zotatifin in Triple-Negative Breast Cancer at 2021 AACR-NCI-EORTC International Conference o

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All